20 (AIDX) Operating Leases (2024 - 2026)

20 posted quarterly Operating Leases of $429122.0 for Q1 2026, down 12.2% on a QoQ basis from $488725.0 in Q4 2025.

20 (AIDX) has 3 years of Operating Leases data on file, last reported at $429122.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $429122.0; the trailing twelve-month figure through Mar 2026 stood at $429122.0 (changed N/A YoY), and the FY2025 full-year result was $488725.0, down 27.47% from the prior year.
  • Operating Leases for Q1 2026 stood at $429122.0, down from $488725.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $673848.0 in Q4 2024 and bottomed at $429122.0 in Q1 2026.
  • The 3-year median for Operating Leases is $488725.0 (2025), against an average of $530565.0.
  • Peak annual rise in Operating Leases reached 27.47% in 2025, while the deepest fall reached 27.47% in 2025.
  • A 3-year view of Operating Leases shows it stood at $673848.0 in 2024, then decreased by 27.47% to $488725.0 in 2025, then fell by 12.2% to $429122.0 in 2026.
  • The last three Operating Leases figures came in at $429122.0 (Q1 2026), $488725.0 (Q4 2025), and $673848.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 20 - - 62,884.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 429,122.00
Dec 31, 2025 488,725.00
Dec 31, 2024 673,848.00